(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Jan ...
CHICAGO — Patients with severe triple-vessel heart disease who underwent a less-invasive stent procedure fared just as well as those who underwent open-heart bypass surgery after 5 years, the FAME 3 ...
MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...
For many, the thought of heart bypass surgery comes with the fear of slowing down, giving up adventures, and leading a ...
Madrid, Spain – 1 September 2025: After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to ...
Please provide your email address to receive an email when new articles are posted on . Patients with prior bypass surgery who need PCI had better 1-year results when the procedure was performed on ...